“…It interacts with guanine and adenine N7 atoms located in the DNA major groove, leading to DNA bending and interfering with its replication, transcription as well as other nuclear functions, thus, arresting cancer cell proliferation and tumor growth (Cepeda et al, 2007). Despite its clinical success, intravenous Cis administration can lead to nephrotoxicity, bone marrow toxicity, intractable vomiting, peripheral neuropathy, deafness, seizures and blindness (Genc et al, 2014;Wang et al, 2014). Drug resistance during therapy is another important limitation to its use requiring the use of increasing doses (Dzamitika et al, 2006).…”